Skip to main content
World Today News
  • Home
  • News
  • World
  • Sport
  • Entertainment
  • Business
  • Health
  • Technology
Menu
  • Home
  • News
  • World
  • Sport
  • Entertainment
  • Business
  • Health
  • Technology
AI Identifies Bladder Cancer Risk Five Years Before Diagnosis, Study Finds

AI Identifies Bladder Cancer Risk Five Years Before Diagnosis, Study Finds

November 22, 2026 Health Desk Health

Researchers have developed an artificial intelligence system capable of identifying bladder cancer risk up to five years before a formal clinical diagnosis.

The tool, which analyzes electronic health records to spot patterns previously overlooked by standard screening, could facilitate earlier intervention for a disease that currently causes approximately 220,000 deaths annually worldwide, ScienceDaily reported.

Key Clinical Takeaways:

  • The PRECISE-AGZ model correctly identified 85% of bladder cancer cases and 91% of non-cancerous cases in a study of nearly 70,000 patients.
  • The system flagged warning signs in some patients up to five years before their actual diagnosis by analyzing 38 key health indicators.
  • The tool classifies patients into low, uncertain, and high-risk groups, potentially reducing the need for invasive cystoscopy procedures in low-risk individuals.

Current clinical protocols for bladder cancer rely heavily on the presence of hematuria, or visible blood in the urine. Because this symptom often overlaps with common conditions like kidney stones or prostate enlargement, diagnostic delays remain a major hurdle in standard care.

To address this, a team led by Professor Shang-Ming Zhou at the University of Plymouth’s Centre for Health Technology utilized electronic medical records from 1995 through 2020 to build the PRECISE-AGZ model.

The model’s performance surpassed existing clinical referral guidelines during the study, according to Technewsreel.com. By processing 48,261 potential health indicators, the system isolated 38 specific features—ranging from medication histories to comorbid conditions—that provided the highest predictive power for bladder cancer.

Risk Category Probability Threshold
Low-Risk Below 7%
Uncertain (Grey Zone) 7% – 55%
High-Risk Above 55%

The AI research, published in IEEE Transactions on Biomedical Engineering, revealed unexpected associations that merit further investigation. For instance, long-term use of tamoxifen was linked to a higher risk, while patients with dementia or Parkinson’s disease appeared to have a lower risk profile. Researchers emphasized that these findings do not prove direct causation. Instead, they suggest that complex biological mechanisms might be at play, warranting closer scrutiny by oncologists and neurologists. “Our system goes far beyond traditional symptoms, and it’s great to have uncovered the results that we have,” said Xu Wang, a PhD student involved in the analysis. The study involved collaboration with clinicians at North Bristol NHS Trust and University Hospitals Bristol NHS Foundation Trust. The potential for this technology lies in its ability to stratify patient risk, which could allow healthcare providers to prioritize diagnostic resources more effectively.

Dr. Helen Winter, Clinical Director for the Somerset, Wiltshire, Avon and Gloucestershire Cancer Alliance, said that the current lack of a routine screening program for the general population makes this type of tool a significant prospect for improving survival outcomes. Despite these results, the research team cautioned that the model requires broader validation before it can be integrated into routine clinical practice. Because the study relied on data from the SAIL database in Wales, future efforts will focus on testing the AI across diverse patient populations and different electronic health record architectures.

Professor Zhou characterized the development as a shift toward precision screening, though he confirmed that additional studies are necessary to verify the causal relationships identified by the algorithm. Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.

The University of Plymouth traces its origins to the Plymouth School of Navigation, founded in 1862, and gained university status in 1992 alongside the other polytechnics. Today it is a public research university with 18,410 students, making it the 57th largest in the United Kingdom by total enrollment, and runs specialist courses in maritime business, marine engineering, marine biology, and Earth, ocean and environmental sciences.

In 2008 the Royal Statistical Society selected the university as the home of its Centre for Statistical Education, underscoring a longstanding strength in quantitative research that aligns with the data-intensive approach behind the PRECISE-AGZ model.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Keep reading

  • WhatsApp Tests Native Cloud Backup for Android With 2 GB Free Encrypted Storage
  • Dak Lak Police Cite Two, Invite One Over False HIV Pickleball Claims
  • Pope Leo XIV Cleared for South America Tour After Lung Cancer Surgery (newsdirectory3.com)
  • FMBA Begins Clinical Use of Oncopept Colorectal Cancer Vaccine (time.news)

Related

Search:

World Today News

World Today News is your trusted source for global journalism — breaking headlines, in-depth analysis, and reporting from around the world.

Quick Links

  • Privacy Policy
  • About Us
  • Accessibility statement
  • California Privacy Notice (CCPA/CPRA)
  • Contact
  • Cookie Policy
  • Disclaimer
  • DMCA Policy
  • Do not sell my info
  • EDITORIAL TEAM
  • Terms & Conditions

Browse by Location

  • GB
  • NZ
  • US

Connect With Us

© 2026 World Today News. All rights reserved. Your trusted global news source directory.
For contact, advertising, copyright, issues email: [email protected]

Privacy Policy Terms of Service